0001171843-23-007357.txt : 20231130 0001171843-23-007357.hdr.sgml : 20231130 20231130090445 ACCESSION NUMBER: 0001171843-23-007357 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20231130 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20231130 DATE AS OF CHANGE: 20231130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 231454085 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 8-K 1 f8k_113023.htm FORM 8-K
false 0000882796 0000882796 2023-11-30 2023-11-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 30, 2023

 

BioCryst Pharmaceuticals, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware 000-23186 62-1413174
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)

 

4505 Emperor Blvd., Suite 200

Durham, North Carolina 27703

(Address of Principal Executive Offices) (Zip Code)

 

(919) 859-1302
(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock BCRX Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 7.01. Regulation FD Disclosure.

 

BioCryst Pharmaceuticals, Inc. (the “Company” or “BioCryst”) reports that it has updated its commercialization agreement with Torii Pharmaceutical Co., Ltd. (“Torii”) for ORLADEYO® (berotralstat) in Japan. Under the terms of the updated agreement, BioCryst, through its Japanese subsidiary, BioCryst Japan K.K., will now be responsible for all commercial promotion activities to support ORLADEYO sales in Japan and Torii will be responsible for hereditary angioedema (HAE) disease awareness activities in Japan. In connection with the updates, the royalty structure has been amended so that BioCryst will receive a 20 percent royalty on annual Japanese sales below a prespecified threshold and an 80 percent royalty on annual Japanese sales above the prespecified threshold.

 

The information in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

 

 

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date:  November 30, 2023 BioCryst Pharmaceuticals, Inc.
 

 

 

By:

 

 

/s/ Alane Barnes

    Alane Barnes
    Chief Legal Officer

 

 EX-101.SCH 2 bcrx-20231130.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 bcrx-20231130_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 4 bcrx-20231130_pre.xml XBRL PRESENTATION FILE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Nov. 30, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 30, 2023
Entity File Number 000-23186
Entity Registrant Name BioCryst Pharmaceuticals, Inc.
Entity Central Index Key 0000882796
Entity Tax Identification Number 62-1413174
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 4505 Emperor Blvd.
Entity Address, Address Line Two Suite 200
Entity Address, City or Town Durham
Entity Address, State or Province NC
Entity Address, Postal Zip Code 27703
City Area Code (919)
Local Phone Number 859-1302
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol BCRX
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 6 f8k_113023_htm.xml IDEA: XBRL DOCUMENT 0000882796 2023-11-30 2023-11-30 iso4217:USD shares iso4217:USD shares false 0000882796 8-K 2023-11-30 BioCryst Pharmaceuticals, Inc. DE 000-23186 62-1413174 4505 Emperor Blvd. Suite 200 Durham NC 27703 (919) 859-1302 false false false false Common Stock BCRX NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://biocryst.gcs-web.com/role/Cover Cover Cover 1 false false All Reports Book All Reports bcrx-20231130.xsd bcrx-20231130_lab.xml bcrx-20231130_pre.xml f8k_113023.htm http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "f8k_113023.htm": { "nsprefix": "BCRX", "nsuri": "http://biocryst.gcs-web.com/20231130", "dts": { "schema": { "local": [ "bcrx-20231130.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "bcrx-20231130_lab.xml" ] }, "presentationLink": { "local": [ "bcrx-20231130_pre.xml" ] }, "inline": { "local": [ "f8k_113023.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://biocryst.gcs-web.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-11-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "f8k_113023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-11-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "f8k_113023.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://biocryst.gcs-web.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0001171843-23-007357-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-23-007357-xbrl.zip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